Promacta
Hi Sally,
Then Don is participating in the second trial for MDS patients - as you can see this study was presented in 2009 and should have 30 patients. I think everything with Promacta seems to take very long time for MDS patients. Now we can only hope that the drug will have good effect - as you know bleedings is a very common death cause in MDS. Only infections are more dangerous.
Kind regards
Birgitta-A
|